The Community Diabetes Education (CoDE) Program
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
Cost-effectiveness of a Genetic Test for Breast Cancer Risk
A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis
A Review and Analysis of Economic Models of Prevention Benefits
Health Benefits and Cost-Effectiveness of a Hybrid Screening Strategy for Colorectal Cancer
Modeling the Impact of Increased Adherence to Asthma Therapy
The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
The Global Outcomes Score: A Quality Measure, Based On Health Outcomes, That Compares Current Care To A Target Level Of Care
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force
A Simulation Shows Limited Savings From Meeting Quality Targets Under The Medicare Shared Savings Program
Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model
Cost-Effectiveness Analysis of a Community Health Worker Intervention for Low-Income Hispanic Adults with Diabetes
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
Physicians’ Actions And Influence, Such As Aggressive Blood Pressure Control, Greatly Improve The Health Of Diabetes Patients
An Estrogen Model: The Relationship between Body Mass Index, Menopausal Status, Estrogen Replacement Therapy, and Breast Cancer Risk
Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectiveness Study in Diabetic Populations
Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients with Severe Hypertriglyceridemia.
Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs.
Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population
Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population.
Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma.
Cost-effectiveness of adding information about common risk alleles to current decision models for breast cancer chemoprevention.
Age at Initiation and Frequency of Screening to Detect Type 2 Diabetes: A Cost-Effectiveness Analysis
Model-Based Benefit-Risk Assessment: Can Archimedes Help?
Preventing Myocardial Infarction and Stroke With a Simplified Bundle of Cardioprotective Medications
Effect of Smoking Cessation Advice on Cardiovascular Disease
The Relationship between Insulin Resistance and Related Metabolic Variables to Coronary Artery Disease: A Mathematical Analysis
A Physiology-Based Mathematical Model of Coronary Heart Disease Accurately Predicts CHD Event Rates in Real Populations
The potential effects of HEDIS performance measures on the quality of care
The Impact of Prevention on Reducing the Burden of Cardiovascular Disease
Validation of Prediction of Diabetes by Archimedes and Comparison with Other Predicting Models.
The Metabolic Syndrome and Cardiovascular Risk: Implications for Clinical Practice.
Diabetes Risk Calculator: A Simple Tool for Detecting Undiagnosed Diabetes and Prediabetes.
Cure, Care, and Commitment: What Can We Look Forward To?
Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy
Medical Decision-making: Why it must, and how it can, be improved
Archimedes: A Bold Step Into The Future
Linking Electronic Medical Records To Large-Scale Simulation Models: Can We Put Rapid Learning On Turbo?
Accuracy versus transparency in Pharmacoeconomic modelling: finding the right balance.
Bringing health economic modeling to the 21st century.
Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Earlier intervention in type 2 diabetes: The case for achieving early.
Evidence-based medicine: a unified approach.
Validation of the Archimedes diabetes model.
Archimedes: a trial-validated model of diabetes.
Archimedes: a new model for simulating health care systems – the mathematical formulation.